In this manuscript, a 28 years old female who developed prostetic valve endocarditis due to vancomycinresistant Enterococcus faecium was presented and the literature was discussed.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Endocarditis due to vancomycine resistant enteroccoci is very rare and it is commonly developed as an nosocomialinfection.
📊
Key Findings & Data:Endocarditis due to vancomycine resistant enteroccoci is very rare and it is commonly developed as an nosocomialinfection.
💡
Conclusion & Impact:In this manuscript, a 28 years old female who developed prostetic valve endocarditis due to vancomycinresistant Enterococcus faecium was presented and the literature was discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Endocarditis due to vancomycine resistant enteroccoci is very rare and it is commonly developed as an nosocomialinfection. In this manuscript, a 28 years old female who developed prostetic valve endocarditis due to vancomycinresistant Enterococcus faecium was presented and the literature was discussed.
Özet
Vankomisine dirençli enterokok (VRE) lara bağlı proste¬tik kapak endokarditi oldukça nadirdir ve sıklıkla hastanekaynaklı olarak gelişebilir. Burada, vankomisine dirençli Enterococcus faeciuma bağlı prostetik kapak endokarditigelişen 28 yaşında bir kadın olgu sunulmuş ve literatür tartışılmıştır.
🔖
Cite This Article
KATIRCIOĞLU, S. F., KESKİN, A., YAPAR, G. T., ALTI, N., SOLGUN, G., ŞENCAN, İ., CESUR, S. (2022). A Case of Prosthetic Valve Endocarditis Due to Vancomycin-Resistant Enterococcoccus faecium. Ortadoğu Tıp Dergisi, Cilt: 5 - Sayı: 4, 233–236. https://ajindex.com/articles/585957
Stevens MP, Edmond MB. Endocarditis due to vancomycin-resist- ant enterococci: case report and review of the literature. Clin Infect Dis. 2005; 41(8):1134-42
LeClercq R, Erlot E, Duval J, Courvalin P. Plasmid-mediated re- sistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319(3):15761
Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Au- bry A,et al. Long-term control of vancomycin-resistant Entero- coccus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill. 2012; 26;17(30). pii: 20229
Calfee DP. Methicillin-resistant Staphylococcus aureus and van- comycin-resistant enterococci, and other Gram-positives in health- care. Curr Opin Infect Dis. 2012;25(4):385-94
Colak D, Naas T, Gunseren F, Fortineau N, Ogunc D, Gultekin M, Nordmann P. First outbreak of vancomycin-resistant entero- cocci in a tertiary hospital in Turkey. J Antimicrob Chemother. 2002;50(3):397-401
Bishara J, Sagie A, Samra Z, Pitlik S. Polymicrobial endocarditis caused by methicillin-resistant Staphylococcus aureus and glyc- opeptide-resistant enterococci. Eur J Clin Microbiol Infect Dis 1999; 18(9):6745
Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345 (18):131830
Forrest GN, Arnold RS, Gammie JS, Gilliam BL. Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect. 2011; 63 (6):420-8
Tiong IY, Novaro GM, Jefferson B, Monson M, Smedira N, Penn MS.Bacterial endocarditis and functional mitral stenosis: a report of two cases and brief literature review. Chest 2002; 122(6):225962
Furlong WB, Rakowski TA. Therapy with RP 59500 (quinupris- tin/ dalfopristin) for prosthetic valve endocarditis due to entero- cocci with VanA/VanB resistance patterns. Clin Infect Dis 1997; 25(1):1634
Yelamanchili S, Cunliffe NA, Miles RS. Prosthetic valve endo- carditis caused by a vancomycin-resistant Enterococcus faecalis. J Infect 1998;36(3):3489
Carfagna P, Tarasi A, Cassone M, Del Grosso MF, Bianco G, Ven- ditti M. Prosthetic biologic valve endocarditis caused by a vanco- mycinresistant (vanA) Enterococcus faecalis: case report. J Chem- other 2000;12(5):41620
Safdar A, Bryan CS, Stinson S, Saunders DE. Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clin Infect Dis 2002; 34(11):E61-3